That's not really the case. Most deals are usually flagged by announcements to the market that the co. are appointing corporate advisors thereby putting the market on notice. The issue for the market participants of course is to differentiate between the quality and likelihood of any such corporate activity occurring in the future. For example Acrux (ACR) announced the appointment of Credit Suisse as corporate advisor approx 4 months before the Eli Lilly deal.
That's not really the case. Most deals are usually flagged by...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.14 |
Change
1.150(5.48%) |
Mkt cap ! $2.829B | |||
| Open | High | Low | Value | Volume |
| $21.50 | $22.44 | $21.50 | $13.15M | 598.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 437 | $22.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $22.15 | 8325 | 7 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |